-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - evaluated losartan versus enalapril
versus amlodipine over 6 months and reported one death due to pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - of This Intervention
A patient initially presents with symptoms that indicate a possible case of pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - examinations, screenings,
evaluations, and interventions for
musculoskeletal, neurological,
cardiovascular, pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - Point of This Intervention
A patient initially presents with symptoms that indicate a possible case of pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - extended-release oxybutynin
or Tolterodine would present
undue risk (medically
uncontrolled cardiovascular,
pulmonary